Category: Equity: Sectoral-Pharma and Healthcare |
Launch Date: 09-06-2025 |
Asset Class: Equity |
Benchmark: BSE Healthcare TRI |
TER: 2.28% As on (31-08-2025) |
Status: Open Ended Schemes |
Minimum Investment: 1000.0 |
Minimum Topup: 1000.0 |
Total Assets: 638.12 Cr As on 29-08-2025(Source:AMFI) |
Turn over: - | Exit Load: Redemption/ switch out of units upto 10% of the units allotted before 1 year from date of allotment Exit load NIL,For redemption/switch out of units above 10% of units allotted within 1 year from the date of allotment: 1.00% of applicable NAV, For redemption/switch out of units after 1 year from the date of allotment: Nil |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.
Standard Deviation | - |
Sharpe Ratio | - |
Alpha | - |
Beta | - |
Yield to Maturity | - |
Average Maturity | - |
Small Cap
25.65%
Others
5.84%
Large Cap
48.1%
Mid Cap
20.41%